HIVE Blockchain Technologies (CVE:HIV) Upgraded at Roth Capital

Roth Capital upgraded shares of HIVE Blockchain Technologies ( CVE:HIV – Free Report ) to a strong-buy rating in a research note published on Wednesday, Zacks.com reports. HIV has been the subject of several other reports.

Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Read Our Latest Stock Analysis on HIVE Blockchain Technologies HIVE Blockchain Technologies Price Performance Featured Stories Five stocks we like better than HIVE Blockchain Technologies Why Understanding Call Option Volume is Essential to Successful Options Trading Opal Fuels CEO on Steering the Future of Renewable Natural Gas CD Calculator: Certificate of Deposit Calculator MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win Industrial Products Stocks Investing 2 Underrated Quantum Computing Companies Starting to Rally Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.



com's FREE daily email newsletter ..